asparagine and Carcinoma, Non-Small Cell Lung

asparagine has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Hanada, K; Itatani, Y; Kawada, K; Maekawa, H; Miyoshi, H; Nishikawa, G; Obama, K; Taketo, MM1
Chen, H; Cui, J; Fan, L; Fu, Y; Han, K; Hu, H; Yin, S; Zhao, C; Zhao, S1
Dohmae, N; Hattori, A; Hirano, Y; Ikeda, H; Kakeya, H; Nishio, K; Pan, Y; Sakai, K; Suzuki, T1
Bougioukas, G; Bouros, D; Gatter, KC; Giatromanolaki, A; Harris, AL; Koukourakis, MI; Pezzella, F; Sivridis, E; Turley, H1
Dorr, RT; Fanta, P; Hersh, EM; Salmon, SE; Taylor, CW1

Trials

1 trial(s) available for asparagine and Carcinoma, Non-Small Cell Lung

ArticleYear
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:1

    Topics: Adult; Antineoplastic Agents; Asparaginase; Asparagine; Carcinoma, Non-Small-Cell Lung; Drug Screening Assays, Antitumor; Glutaminase; Humans; Lung Neoplasms; Melanoma; Neoplasm Proteins; Neoplasms; Polyethylene Glycols; Skin Neoplasms

2001

Other Studies

4 other study(ies) available for asparagine and Carcinoma, Non-Small Cell Lung

ArticleYear
Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
    Cells, 2022, 10-18, Volume: 11, Issue:20

    Topics: Animals; Asparaginase; Asparagine; Aspartate-Ammonia Ligase; Aspartic Acid; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Glutamine; Humans; Lung Neoplasms; Mice; Mice, Nude; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering; Spheroids, Cellular; Xenograft Model Antitumor Assays

2022
Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells.
    Biochemical pharmacology, 2023, Volume: 215

    Topics: Antineoplastic Agents; Asparagine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines

2023
Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
    European journal of pharmacology, 2023, Dec-05, Volume: 960

    Topics: A549 Cells; Asparagine; Aspartate-Ammonia Ligase; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases

2023
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
    Cancer letters, 2008, Apr-08, Volume: 262, Issue:1

    Topics: Asparagine; Carcinoma, Non-Small-Cell Lung; Humans; Hypoxia-Inducible Factor 1; Lung Neoplasms; Mixed Function Oxygenases; Procollagen-Proline Dioxygenase; Repressor Proteins; Transcriptional Activation

2008